ClinicalTrials.gg
Not yet recruitingNCT07509931Updated Apr 3, 2026

Empowerment Training for Personal Agency Development of Primary Health Care Workers

An interventional study of Empowerment Agency Training (EAT) in Data Accuracy, Agency and Burnout, sponsored by Oxford University Clinical Research Unit Indonesia. Not yet recruiting at 2 sites in Indonesia. Per ClinicalTrials.gov, last updated 2026-04-03.

Sponsored by Oxford University Clinical Research Unit Indonesia · Not applicable, Interventional, and Health services research

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Sex
All
01

Study summary

This study evaluates an Empowerment Agency Training (EAT) intervention within the SPHERES programme that aims to strengthen personal agency among workers in primary healthcare centers (Puskesmas) in Indonesia. The intervention focuses on building self-efficacy, behavioural control, leadership, and intentional decision-making through structured training, follow-up action planning, observational support, and sustainability-oriented incentives. Strengthening personal agency is expected to improve the use of data for decision-making and the delivery of priority primary health services at the Puskesmas level.

Read the detailed description

This study evaluates a complex intervention in the form of an Empowerment Agency Training (EAT) implemented as an integral component of the SPHERES programme (NCT07126041) in Indonesia. The intervention is grounded in the recognition that, within digital health ecosystems, investments in technology and data systems have not consistently translated into improved service delivery due to limited individual capacity, behavioural adaptation, and organisational readiness among health workers. The EAT intervention therefore focuses on strengthening personal agency among Puskesmas staff, defined as the capacity to act intentionally, regulate behaviour, exercise leadership, and make informed decisions in complex work environments.

The EAT intervention comprises four interrelated components delivered in an integrated and adaptive manner. First, empowerment through a personal agency approach is delivered via structured training sessions aimed at strengthening self-awareness, self-efficacy, leadership, assertiveness, and mastery of the work environment. Second, participants develop behaviour-related follow-up action plans that translate personal agency concepts into concrete and achievable changes in daily work practices, including communication, task management, teamwork, and the use of health data for decision-making. Third, expert shadowing provides direct observational support to understand real-world service dynamics. Fourth, sustainability-oriented incentives, including opportunities for advanced training and locally governed financial incentives, are used to reinforce engagement and support longer-term adoption of new practices.

Within the SPHERES programme, the digitalisation of health information systems is deliberately complemented by interventions that address human and organisational factors. By embedding EAT within SPHERES, the intervention is designed to ensure that digital tools and data systems are actively interpreted, used, and translated into service improvements, rather than functioning solely as mechanisms for routine reporting.

The intervention is evaluated using a cluster randomised controlled trial design, in which Puskesmas that are already participating in the SPHERES programme are randomly assigned to receive the additional Empowerment Agency Training (EAT) intervention. The study population includes all staff working at participating Puskesmas, with total population sampling applied at the facility level to ensure comprehensive exposure to the intervention and to minimise contamination. To assess service-related outcomes, selected health service users from Puskesmas catchment areas are also included. Community-level sampling for outcome assessment uses probability-based approaches proportional to population size.

Primary outcomes include clinical data quality, including its completeness and submission timeliness, and changes in personal agency and health worker behaviour, particularly the use of health data for planning and decision-making. Additional outcomes include selected priority health service indicators at the Puskesmas level, such as coverage and quality of maternal, child, and non-communicable disease services. Outcome data are derived from validated personal agency survey instruments administered to health workers, as well as routine service data captured through digital health information systems integrated within the SPHERES platform.

The evaluation adopts a convergent mixed-methods approach. Quantitative data are collected longitudinally before and after intervention implementation to assess changes in outcomes over time. Qualitative data from in-depth interviews, focus group discussions, and field observations are collected in parallel to examine contextual factors influencing implementation, mechanisms of change, acceptability, and sustainability of the intervention. Quantitative and qualitative findings are analysed separately and integrated during interpretation to provide a comprehensive understanding of intervention effects and implementation processes.

At a broader level, this study is designed to generate evidence relevant to national health system development in Indonesia. By evaluating a complex, people-centred intervention embedded within a national digital health transformation programme, the findings are expected to inform policy decisions related to health workforce development, digital health scale-up, and the sustainable integration of system-level interventions into routine primary health care across nuanced settings.

02

Conditions studied

  • Data Accuracy
  • Agency
  • Burnout
  • Service Evaluation
  • Assertiveness

Keywords

  • Personal agency
  • Empowerment training
  • Primary health care
  • Health workforce
  • Behaviour change
  • Burnout
  • Data utilisation
  • Digital health
  • Health systems
  • Complex intervention
  • Randomised controlled trial
  • Observation
  • Service delivery improvement
  • Implementation research
  • Indonesia
03

In context

Burnout, Psychological

468 studies on the registry are indexed under Burnout, Psychological; 121 are open to participants now.

This study's planned enrollment of 200 is above the median of 80 across 344 interventional studies indexed under Burnout, Psychological.

Browse Burnout, Psychological studies →

Lead sponsor

Oxford University Clinical Research Unit Indonesia is the lead sponsor of 4 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

- Registered staff of the intervention clusters (PHCs), either as registered civil servant, contract workers, or honorary workers.

Exclusion criteria

Exclusion Criteria:

  • PHC staff who decline to provide .
  • PHC staff who will not retain their employment until the end of the observation period.
  • Participants who are not in good physical and mental condition to attend the training intervention (for the intervention arm).
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Experimental
    Empowerment Training Arm

    Health care providers in the intervention clusters (PHCs).

    Behavioral: Empowerment Agency Training (EAT)

  • No intervention
    Control Arm

    Health care providers in the non-intervention clusters (PHCs).

Interventions

  • BehavioralEmpowerment Agency Training (EAT)

    The intervention comprises a behavioral training program focused on personal agency and empowerment. The curriculum follows the established frameworks developed by The Self-Empowerment and Equity for Change (SEE Change) Initiative at the Johns Hopkins Bloomberg School of Public Health. The training is followed by simple, practical "prescription", or action plans, for behaviour change in daily work. Implementation is supported through direct observation by facilitators (expert shadowing) and incentives, including advanced training opportunities and locally managed financial support.

06

What researchers measure

Primary outcomes

  1. Difference in clinical data quality between intervention and control arms, and changes in personal agency and health worker behaviour

    Clinical data quality is determined by proportion of data entry in the digital health information system compared to the gold standard (legacy reporting system). Other metrics being the heaping index indicating digit preference in numeric clinical data input in various services, and also the proportion of biologically implausible values. Changes in personal agency and health worker behaviour is determined by the proportion of action derived from data-driven discussion, as well as the overall level of patient satisfaction from the care delivery.

    Time frame: Up to 6 months

Secondary outcomes

  1. Completeness of care in maternal and neonatal care

    * of pregnant women with at least six timely ANC services (K1 - K6) * of pregnant women with complete services per ANC encounter * of newborn with at least three timely PNC services (Kn1 - Kn3) * of mothers with newborn with at least four timely PNC services (Kf1 - Kf4) Neonatal mortality rate Stillbirth rate All indicators will be measured using the SPHERES dashboard.

    Time frame: Up to 6 months

  2. Completeness of care in tuberculosis treatment

    * of TB suspect screened * of TB diagnosis from all screened suspects * of TB patients receiving medications * of TP patients being loss to follow-up * of TB patients with complete recovery All indicators will be measured using the SPHERES dashboard.

    Time frame: Up to 6 months

  3. Completeness of care in hypertensive treatment

    * of people screened for hypertension * of people with hypertension diagnosis * of hypertensive patient receiving medications * of hypertensive patient with controlled blood pressure All indicators will be measured using the SPHERES dashboard.

    Time frame: Up to 6 months

  4. Completeness of care in diabetes treatment

    * of people screened * of people with diabetes diagnosis * of diabetes patient receiving medications * of people with controlled HbA1c All indicators will be measured using the SPHERES dashboard.

    Time frame: Up to 6 months

07

Study locations

2 sites
08

References and documents

Individual participant data

Plan to share: No — The study will not share individual participant data due to the population-level nature of the intervention and national data privacy regulations. Only aggregated and de-identified/anonymized data and codebook may be made publicly available upon publication. All data collection, storage, and analysis procedures will comply with Indonesia's Personal Data Protection Law (UU PDP), Ministry of Health guidance, and institutional ethical standards.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Apr 2026; primary completion for Sep 2026, 5 months later.

Of 253 non-industry interventional studies with no phase under Burnout, Psychological, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 24. This study's planned 5 months is below that.

Counting every sponsor, half of 260 studies reached it within 12 months; a quarter within 5 and three quarters within 24.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 25, 2026
First posted
Apr 3, 2026
StartEst.
Apr 10, 2026
Primary completionEst.
Sep 30, 2026
CompletionEst.
Dec 31, 2026
Last update
Apr 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07509931
Lead sponsor
Oxford University Clinical Research Unit Indonesia
Collaborators
District Health Office of Purbalingga District, Indonesia, District Health Office of Lombok Barat District, Indonesia, The Self-Empowerment and Equity for Change (SEE Change) Initiative, The United States
Responsible party
Anuraj Shankar (Anuraj H Shankar, Oxford University Clinical Research Unit Indonesia) — Principal investigator
First posted
Apr 3, 2026
Start date
Apr 10, 2026 (estimated)
Primary completion
Sep 30, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Apr 3, 2026

Study contacts

Ris HN Sitinjak, M.Sc., Pharm.
Contact
rsitinjak@oucru.org
+62-813-4777-9810 ext. +62
Feliciana Amelinda, MD
Contact
famelinda@oucru.org
+62-812-8761-589 ext. +62
Anuraj H Shankar, D.Sc.
principal investigator · Oxford University Clinical Research Unit Indonesia

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion